The Effects of Spironolactone in Preventing Bile Duct Ligation-induced Hepatitis in A Rat Model
In conclusion, i t was observed that SPL administration significantly decreases liver inflammation and damage related to BDL.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Bile | Bilirubin | Cholestasis | Drugs & Pharmacology | Hepatitis | Iran Health | Liver | Liver Disease | Spironolactone | Toxicology | Urology & Nephrology